Following the March meetings of GMMMG and CEGC, the following actions have been published to the GMMMG website.

Updates to guidelines include:

  • Gabapentinoid resource pack re-published
  • Pathway guidance for managing GLP-1 agonist shortages in adults updated
  • Advice on use on tirzepatide published

Formulary and RAG updates include:

  • Foslevodopa with foscarbidopa added as red

Links to NICE guidance and MHRA safety advice added as appropriate. For full details of formulary and RAG updates, see the formulary change log available on the formulary page.

The following decisions await approval by the GM ICB Executive:

  • Cytisine 1.5mg tablets for smoking cessation – Green first line option
  • Empagliflozin for treating chronic heart failure
  • Riluzole shared care protocol (update)
  • Slenyto rebate scheme